Virtual Public Session
Thursday, December 5, 2024 (1:30–3:00 p.m. ET)
Session 1 - Open
| 1:30–1:40 p.m. | Welcome and Introduction Frederick Rivara, Committee Co-Chair Phyllis Dennery, Committee Co-Chair |
| 1:40–2:05 p.m. | Charge to the Committee: Perspective of the Study’s Sponsor Representatives Rohan Hazra, Director, Division of Extramural Research, NICHD Tracy King, Associate Director for Prevention and Medical Officer, Child Development and Behavior Branch, NICHD Sarah Glavin, Deputy Director of Science Policy Analysis and Communication and Chief of Science Policy and Evaluation, NICHD; Co-Chair of NIH’s RCDC Governance Board |
| 2:05–2:30 p.m. | Committee Q&A Session with Sponsor Representatives |
| 2:30–2:45 p.m. | Coalition for Pediatric Medical Research (CPMR) Speakers Tina Cheng, Chief Medical Officer, Cincinnati Children’s Dennis Durbin, President, Abigail Wexner Research Institute at Nationwide Children’s Sallie Permar, Chair, Department of Pediatrics at Weill Cornell Medicine Carl Allen, Chair in Pediatric Oncology, Texas Children’s Hospital |
| 2:45–3:00 p.m. | Committee Q&A Session with Coalition Representatives |
| 3:00 p.m. | Adjourn |
Virtual Public Session
Thursday, March 13, 2025 (9:00–11:00 a.m. ET)
Public Session Part 1 Day 1 - Open
| 9:00–9:10 a.m. | Welcome and Introduction Frederick Rivara, Committee Co-Chair Phyllis Dennery, Committee Co-Chair |
| 9:10 a.m. | Brief Introduction to the Session Mary Leonard, Committee Member |
| 9:10–10:10 a.m. | Perspectives from Larger NIH Initiatives Gaya Dowling, ABCD Project Matthew Gillman, Environmental Influences on Child Health Outcomes Program Sara van Driest, All of Us Research Program Walter Koroshetz, BRAIN Initiative Tiina K. Urv, Rare Diseases Clinical Research Network David Goff and Gail Pearson, RECOVER |
| 10:10–11:00 a.m. | Committee Q&A with Panelists |
| 11:00 a.m. | Adjourn |
Virtual Public Session
Friday, March 14, 2025 (9:00–11:00 a.m. ET)
Public Session Part 1 Day 2 - Open
| 9:00–9:10 a.m. | Welcome and Introduction Frederick Rivara, Committee Co-Chair Phyllis Dennery, Committee Co-Chair |
| 9:10 a.m. | Brief Introduction to the Session Brendan Lee, Committee Member |
| 9:10–9:25 a.m. | NIH Center for Scientific Review Valerie Durrant, NIH Center for Scientific Review |
| 9:25–9:45 a.m. | Committee Q&A |
| 9:45 a.m. | Brief Introduction to the Session Rosemary Higgins, Committee Member |
| 9:45–10:10 a.m. | Perspectives from NICHD Diana Bianchi, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Rohan Hazra, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| 10:10–10:30 a.m. | Committee Q&A |
| 10:30 a.m. | Brief Introduction to the Session Pamela Hinds, Committee Member |
| 10:30–10:45 a.m. | NIH Clinical Center Colleen Hadigan, NIH Clinical Center |
| 10:45–11:00 a.m. | Committee Q&A |
| 11:00 a.m. | Adjourn |
Virtual Public Session
Thursday, March 27, 2025 (9:30–10:35 a.m. ET)
Public Session Part 2 Day 1 - Open
| 9:30–9:35 a.m. | Welcome and Introduction Frederick Rivara, Committee Co-Chair Phyllis Dennery, Committee Co-Chair |
| 9:35 a.m. | Brief Introduction to the Session Glenn Flores, Committee Member |
| 9:35–10:05 a.m. | Disease Categorization and Analysis at NIH Mara Olenick, Division of Scientific Categorization and Analysis, Office of Research Reporting and Analysis, Office of Extramural Research, NIH Sarah Glavin, Science Policy, Planning, and Evaluation Branch, Office of Science Policy, Reporting, and Program Analysis, NICHD |
| 10:05–10:35 a.m. | Committee Q&A Moderator: Glenn Flores |
| 10:35 a.m. | Adjourn |
Virtual Public Session
Friday, March 28, 2025 (9:00–11:00 a.m. ET)
Public Session Part 2 Day 2 - Open
| 9:00–9:10 a.m. | Welcome and Introduction Frederick Rivara, Committee Co-Chair Phyllis Dennery, Committee Co-Chair |
| 9:10–10:15 a.m. | Perspectives from NIH Institutes, Centers, and Offices on Pediatric Research Michael Chiang, National Eye Institute (NEI) Gaya Dowling, National Institute on Drug Abuse (NIDA) John Glod and Brigitte Widemann, National Cancer Institute (NCI) Kimberly Gray, National Institute of Environmental Health Sciences (NIEHS) Amelia Karraker, National Institute on Aging (NIA) Kelly King, National Institute on Deafness and Other Communication Disorders (NIDCD) George Koob, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Jeanne Marrazzo, National Institute of Allergy and Infectious Diseases (NIAID) Susan Mendley, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Eliseo Pérez-Stable, National Institute on Minority Health and Health Disparities (NIMHD) Ann Poduri, National Institute of Neurological Disorders and Stroke (NINDS) Jennifer Webster-Cyriaque, National Institute of Dental and Craniofacial Research (NIDCR) |
| 10:15–11:00 a.m. | Committee Q&A |
| 11:00 a.m. | Adjourn |
Virtual Public Session
Monday, April 21, 2025 (3:00–4:00 p.m. ET)
Public Session Part 3 - Open
| 3:00–3:05 p.m. | Welcome and Introduction Frederick Rivara, Committee Co-Chair |
| 3:05–3:50 p.m. | Disease Categorization and Analysis at NIH Sarah Glavin, Science Policy, Planning, and Evaluation Branch, Office of Science Policy, Reporting, and Program Analysis, NICHD |
| 3:50–4:00 p.m. | Committee Q&A Moderator: Christopher Forrest |
| 4:00 p.m. | Adjourn Phyllis Dennery, Committee Co-Chair |